A detailed history of Ziegler Capital Management, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 17,819 shares of ARCT stock, worth $301,319. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,819
Previous 16,695 6.73%
Holding current value
$301,319
Previous $526,000 14.26%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $35,102 - $48,320
1,124 Added 6.73%
17,819 $601,000
Q3 2023

Oct 16, 2023

SELL
$25.44 - $37.35 $2,671 - $3,921
-105 Reduced 0.63%
16,695 $426,000
Q2 2023

Jul 25, 2023

BUY
$23.94 - $32.36 $402,192 - $543,648
16,800 New
16,800 $481,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $449M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.